Many foods, herbs and other plants have proven highly effective in killing cancer cells in the laboratory. Perhaps the best known example is cannabis, whose active constituents, cannabinoids, has been shown to destroy cancers of all types. The problem has been the understanding of the various strains and quality of cannabis and how it interacts with each person differently. Clinical trials help, but there have been few.
The little known Chinese herb artemisinin is another example. According to studies published in Life Sciences, Cancer Letters, and Anticancer Drugs, this derivative of the wormwood plant, which is commonly used in Chinese medicine, can kill cancer cells, and do it at a pace 12,000 cancer cells for every healthy cell.
Another plant once used medicinally by ancient civilizations is proving effective as well. Call Noni Leaf, which is derived from a small evergreen that grows in the Pacific Islands, Southeast Asia, Australia and India, among the lava flows. It has been studied for its many health benefits, and a fairly recent study published in Molecular and Cellular Biochemistry is showing that this food is consumed as a vegetable (leaves Noni), it could be ideal for the treatment, prevention and / or treatment of lung cancer.
The study found that an extract of noni leaf was more effective than erlotinib, the chemotherapy drug used to suppress the metastasis of lung cancer, in the treatment of lung cancer in an animal model.
The authors also note how chemotherapy and / or radiotherapy conventional commonly fails when it comes to lung cancer. And this is not new information. A survey in 1985 found that only about one-third of physicians and oncology nurses have consented to chemotherapy for small-cell carcinoma (NSCLC). Lung cancer is the deadliest of all cancers, claiming 1.4 million lives each year, and most of these cases are classified as NSCLC.
Scientists compared Noni left in the development of lung cancer with metastasis both in vitro and in vivo with anticancer drug approved by the FDA Erlotinib. What is the difference between in vivo and in vitro? For in vitro studies, researchers conduct experiments using cells in a petri dish, or perform a procedure outside a controlled environment of a living organism. For in vivo studies, researchers conduct experiments as a whole, living organism as opposed to a partial or dead organism. Animal studies and clinical trials are two forms of in vivo research.
The study found that the leaf extract noni “inhibits proliferation and induced apoptosis in A549 cells and lung carcinoma mouse Lewis in vitro [and] cell cycle arrest cancer in G0 / G1. ” The summary will outline further results:
showed no toxicity in normal lung cells, and mentioned that: small-cell carcinoma no BALB / c A549 induced (NSCLC) were fed 150 300 mg / kg M. citrifolia and compared with erlotinib (50 mg / kg body weight) for 21 days. It increased significantly the TRP53 pro-apoptotic down regulated genes, pro-tumourignensis genes in tumors of mice, significantly increased the anti-inflammatory IL-4, IL-10 and NR3C1 expression in the lung metastases and tissues of liver cancer and improved the NFE2L2-dependent antioxidant responses against oxidative damage. The high serum extract neutrophils and reduced the concentration of red blood cells, hemoglobin, mean corpuscular volume and hemoglobin cell in the mammal induced lung cancer. inflammation and edema is suppressed, and upregulated endogenous antioxidant responses and apoptotic genes to suppress cancer. Extract 300 mg / kg was more effective than the 50 mg / kg erlotinib for most measured parameters.
Pretty amazing, right? These results certainly warrant further research and clinical trials in humans. The changes produced by the noni leaf are consistent with what researchers expected a good chemotherapy drug, so this type of medication is classified as “alternative” is a mystery. In fact, 25 percent of the active ingredients in drugs against cancer is found only in the Amazon, however, only 10 percent of the plants of the Amazon have been studied for their medicinal properties.
Cancer is big business
“We have an industry of billions of dollars that is killing people, right and left, just for financial gain. His idea of research is to determine whether two doses of this poison is better than three doses of that poison. ”
– Glen Warner, M. D. oncologist
Unfortunately, cancer is big business, promising huge and endless profits for pharmaceutical companies. This is far from a conspiracy theory; there is a reason why many experts in the field are speaking against the cancer industry. Linus Pauling, for example, a winner of the Nobel Prize twice, told the world that research more cancer is largely a fraud and that the major organizations cancer research are “negligent in their duties to the people who They support them. ”
Arnold Relman Seymour (1923-2014), professor of medicine at Harvard University and former chief editor of the New England Medical Journal, said that “the medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. the academic institutions in this country are allowing themselves as paid agents of the pharmaceutical industry. ”
The list of statements from industry experts is very wide, and the number of substances out there that show extreme potential for cancer treatment is equally great. Unfortunately, it seems that drug companies to be interested in many of them, since most can not be patented or benefited from.
Sayer Ji Greenmedinfo sums it up best:
The implications of this research are truly profound. Erlotinib (trade name Tarceva) can cost more than $ 7.700 per month (150 mg one day), depending on the dose of the drug used. Ironically, since the drug actually does not prolong survival effectively, salsa circulations dry trains profits sooner rather than later, because the patient dies. If indeed the drug prolongs survival of a year, would it be worth the 30,000 to 90,000 it costs? Perhaps, if you can afford it. When the price of noni leaf extract, which can cost as little as 12 cents per 250 mg of extract, you begin to see how skewed our concept of value is compared. How is it possible that a chemotherapy agent with deadly side effects, which can easily bankrupt a family if they are forced to pay out of pocket, is offered as the only option for people with cancer when something that is virtually free , safe, and has been shown effective in this way?
Below is an article published in the cancer industry is seen in this corruption in depth as well as a video of reflection (taken from the documentary Thrive) to give you something to think shown. cancer problems that not many people are addressing are summarized.